Evidence map›Paper›PMID 23727981›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2014

Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria.

Muktar H Aliyu, Meridith Blevins, Deidra D Parrish, Karen M Megazzini, Usman I Gebi, Mukhtar Y Muhammad, Mukhtar L Ahmed, Adiba Hassan, Bryan E Shepherd, Sten H Vermund and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Diagnosis of Human Immunodeficiency Virus Infection.Clinical microbiology reviews · 2019
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Correlates of suboptimal entry into early infant diagnosis in rural north central Nigeria.Journal of acquired immune deficiency syndromes (1999) · 2014
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Muktar H AliyuDepartments of *Preventive Medicine, †Medicine, and ‡Biostatistics, Vanderbilt Institute for Global Health, Nashville, TN; §Westat, Rockville, MD; ‖Friends in Global Health, Abuja, Nigeria; ¶US Centers for Disease Control and Prevention, Abuja, Nigeria; and the #Department of Pediatrics, Vanderbilt Institute for Global Health, Nashville, TN.
Meridith Blevins
Deidra D Parrish
Karen M Megazzini
Usman I Gebi
Mukhtar Y Muhammad
Mukhtar L Ahmed
Adiba Hassan
Bryan E Shepherd
Sten H Vermund
C William Wester
General Department of Preventive Medicine · VNFriends United · USVanderbilt Health · USCenters for Disease Control and Prevention · UGWestat (United States) · US

Funding

Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
"Implementation of Programs for Prevention, Care and Treatment of HIV/AIDS in theU2GPS001063 · PS · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2008 to 2013
$11.6M
Optimizing integrated PMTCT services in rural North-Central NigeriaR01HD075075 · NICHD · VANDERBILT UNIVERSITY · PI ALIYU, MUKTAR HASSAN · 2012 to 2013
$895k
FIC NIH HHS R24 TW007988FIC NIH HHS R24TW007988NCHHSTP CDC HHS U2G PS001063NICHD NIH HHS R01 HD075075PEPFAR
6 · The paper itself

Abstract

backgroundTimely initiation of combination antiretroviral therapy (ART) in eligible HIV-infected patients is associated with substantial reduction in mortality and morbidity. Nigeria has the second largest number of persons living with HIV/AIDS in the world. We examined patient characteristics, time to ART initiation, retention, and mortality at 5 rural facilities in Kwara and Niger states of Nigeria.

methodsWe analyzed program-level cohort data for HIV-infected ART-naive clients (≥15 years) enrolled from June 2009 to February 2011. We modeled the probability of ART initiation among clients meeting national ART eligibility criteria using logistic regression with splines.

resultsWe enrolled 1948 ART-naive adults/adolescents into care, of whom, 1174 were ART eligible (62% female). Only 74% of the eligible patients (n = 869) initiated ART within 90 days after enrollment. The median CD4 count for eligible clients was 156 cells/μL (interquartile range: 81-257), with 67% in WHO stage III/IV disease. Adjusting for CD4 count, WHO stage, functional status, hemoglobin, body mass index, sex, age, education, marital status, employment, clinic of attendance, and month of enrollment, we found that immunosuppression [CD4 350 vs. 200, odds ratio (OR) = 2.10, 95% confidence interval (CI): 1.31 to 3.35], functional status [bedridden vs. working, OR = 4.17 (95% CI: 1.63 to 10.67)], clinic of attendance [Kuta Hospital vs. referent: OR = 5.70 (95% CI: 2.99 to 10.89)], and date of enrollment [December 2010 vs. June 2009: OR = 2.13 (95% CI: 1.19 to 3.81)] were associated with delayed ART initiation.

conclusionsDelayed initiation of ART was associated with higher CD4 counts, lower functional status, clinic of attendance, and later dates of enrollment among ART-eligible clients. Our findings provide targets for quality improvement efforts that may help reduce attrition and improve ART uptake in similar settings.

Indexed as

Rural PopulationAdultAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountCohort StudiesFemaleHealth Services ResearchHIV InfectionsHumansMaleNigeriaPregnancyRisk FactorsSurvival AnalysisTime FactorsAnti-Retroviral Agents

Identifiers

PMID23727981
PMCPMC3818360
OpenAlexW2076992782

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.